Tevogen Bio Holdings Inc.
TVGN
$7.00
-$2.54-26.63%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -5.45M | -4.68M | -5.73M | -5.50M | -10.37M |
| Total Depreciation and Amortization | 59.10K | 85.80K | 27.20K | 290.80K | 105.40K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.82M | 2.44M | 3.18M | 3.24M | 7.30M |
| Change in Net Operating Assets | -170.30K | -32.10K | -1.13M | -1.21M | -349.80K |
| Cash from Operations | -2.73M | -2.18M | -3.65M | -3.19M | -3.31M |
| Capital Expenditure | -- | -64.40K | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -64.40K | -- | -- | -- |
| Total Debt Issued | 2.00M | 0.00 | 0.00 | 1.40M | 2.00M |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 873.70K | 1.76M | 4.10M | 500.00K | 2.00M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 0.00 | -100.00K | -- | -- |
| Cash from Financing | 2.87M | 1.76M | 4.00M | 1.90M | 4.00M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 139.90K | -484.70K | 351.90K | -1.29M | 691.90K |